title: Ultrafine particles affect experimental thrombosis in an in vivo hamster model.
abstract: Particulate air pollution is associated with cardiovascular morbidity and mortality. To investigate this association, we studied the effect of ultrafine (60 nm) polystyrene particles on thrombus formation in a hamster model after intravenous and intratracheal administration of unmodified, carboxylate-polystyrene, or amine-polystyrene particles. Unmodified particles had no effect on thrombosis up to 5 mg/kg. Carboxylate-polystyrene particles significantly inhibited thrombus formation at 500 and 100 microg/kg body weight but not at 50 microg/kg body weight. In contrast, amine-polystyrene particles significantly enhanced thrombosis at 500 and 50 microg/kg body weight but not at 5 microg/kg body weight. Similarly, the intratracheal instillation of 5,000 microg of amine-polystyrene particles significantly increased thrombus formation. The unmodified particles and carboxylate-polystyrene particles had no effect. During platelet aggregation in human platelet-rich plasma, induced with 1.25 microM ADP, unmodified particles had no effect up to 100 microg/ml, and carboxylate-polystyrene particles weakly enhanced platelet aggregation at 25 to 100 microg/ml. However, amine-polystyrene particles (50 and 100 microg/ml) induced platelet aggregation themselves and strongly increased the ADP-induced aggregation. We conclude that the presence of (ultrafine) particles in the circulation may affect hemostasis. The observed in vivo prothrombotic tendency results, at least in part, from platelet activation by positively charged amine-polystyrene particles.
mesh_terms: D000244:Adenosine Diphosphate / Q000008:administration & dosage; D000818:Animals; D001777:Blood Coagulation / Q000187:drug effects; D003102:Colloids / Q000008:administration & dosage*; D006224:Cricetinae; D004195:Disease Models, Animal; D004305:Dose-Response Relationship, Drug; D005268:Femoral Vein / Q000473:pathology; D006331:Heart Diseases / Q000473:pathology*; D007275:Injections, Intravenous; D018613:Microscopy, Confocal; D008854:Microscopy, Electron; D010316:Particle Size; D052638:Particulate Matter; D010974:Platelet Aggregation / Q000187:drug effects; D011137:Polystyrenes / Q000008:administration & dosage; D012828:Silicones / Q000008:administration & dosage*; D013927:Thrombosis / Q000473:pathology*
chemical_list: D003102:Colloids; D052638:Particulate Matter; D011137:Polystyrenes; D012828:Silicones; D000244:Adenosine Diphosphate